Hi hunnies! We had so many messages about Serena Williams’ weight-loss jab ad that we knew we had to dig deeper behind the headlines into the world of GLP-1s for this extra episode. From the shame still clinging to these drugs, to the groundbreaking new research on how they could help treat psychiatric disorders, addiction and even Alzheimer's, we’re weighing up the pros and cons. We also share how a GLP-1 has transformed the life of one listener with PCOS, ask what’s really driving the obesity epidemic and get into the difference between GLP-1s for medical vs. aesthetic use. We love hearing from you, DM us ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@straightuppod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, email at ⁠⁠[email protected]⁠ and follow us on TikTok @straightuppod too!Reccs:How is Ozempic changing the world? Why? With Emma Kennedy podcastA GLP-1/obesity expert breaking down Jameela Jamil's postHow weight-loss wonder drugs are redefining the way our bodies work, Guardian Here’s Why Doctors Are Hopeful That GLP-1s Can Help Treat PCOS Symptoms, Women's HealthHealth and productivity losses from obesity ‘far outstrip weight-loss jab costs’, GuardianA Year on Ozempic Taught Me We Are Thinking About Obesity All Wrong, New York Times. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related